Click Therapeutics, Inc.
Other Health Care
On its website, the company describes its work as “Click Therapeutics is redefining modern medicine with patient-centric digital treatments. Operating at the intersection of biology and technology, Click combines neuroscience with the power of…”.
Research Click Therapeutics, Inc.
Tracking coverage
Some source history is available; coverage remains limited.
- Momentum +1 · Limited coverage
- The latest public index does not report a rank for this company.Index checked:
- Fundraising +2 · Limited coverage
- Verified filings recorded. Existing baseline history earns no points.SEC source checked:
- New VC +3 · Awaiting data
- No verified dated source evidence recorded.
- Completed exit +10 · Limited coverage
- Homepage checked. Exit news coverage is not established.Homepage checked:
Coverage describes public evidence. Points require a qualifying milestone after your pick.
What it does
On its website, the company describes its work as “Click Therapeutics is redefining modern medicine with patient-centric digital treatments. Operating at the intersection of biology and technology, Click combines neuroscience with the power of…”.
Tracked VC backing
No tracked VC backing recorded.
A portfolio listing documents backing; its observation date is not an investment date.
Dated public activity
· Form D filing · Baseline
Reported sold as filed: $49,999,999 · Offering amount as filed: $49,999,999
SEC source checked 29 Oct 2026. Historical filing, not a current valuation.
View original evidence ↗
History is research context. Only qualifying milestones after your pick earn points.